KerriGlassnerDO

Gastroenterology • Lafayette, CO

Inflammatory Bowel Disease

Physician

Join to view full profile

Dr. Glassner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Glassner's full profile

Already have an account?

Office
280 Exempla Cir
Lafayette, CO 80026
Phone+1 303-338-4545

Fax+1 713-797-0622

Education & Training

Methodist Hospital (Houston)Fellowship, Gastroenterology, 2017 - 2020
Methodist Hospital (Houston)Residency, Internal Medicine, 2014 - 2017
Rocky Vista University College of Osteopathic MedicineClass of 2014, D.O.

Certifications & Licensure

TX State License 2016 - 2026
CO State License 2024 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Gastroenterology

Publications & Presentations

PubMed

1 citations
Postoperative Ustekinumab Drug Levels and Disease Activity in Patients with Crohn's Disease.
Joshua Moskow, Theresa Thurston, Adam Saleh, Ayushi Shah, Bincy P Abraham
Digestive Diseases and Sciences. 2024-08-01
Therapeutic drug monitoring in patients with inflammatory bowel disease on ustekinumab.
Adam Saleh, Rachel Stading, Natalia Miroballi, Kerri Glassner, Bincy P Abraham
Journal of Digestive Diseases. 2024-04-01
Therapeutic drug monitoring in inflammatory bowel disease patients on vedolizumab.
Mohammed Ansari, Kerri Glassner, Malcolm Irani, Adam Saleh, Lin Wang
Journal of Digestive Diseases. 2024-02-01

Press Mentions

MNT Investigates: Can 'Good' Bacteria Treat Crohn's Disease?June 7th, 2022
How Does It Work? Ulcerative Colitis EndoscopyAugust 10th, 2021
The role of gut bacteria in ulcerative colitis July 25th, 2020
Join now to see all